Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
allergan
2
×
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
san francisco blog main
10x genomics
alzheimer's disease
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
crispr
cynthia collins
dana hilt
daprodustat
david chacko
david marek
deals
detroit blog main
detroit top stories
duchenne muscular dystrophy
What
biotech
2
×
abbvie
alliance
august
bio
busy
days
decisions
devices
drugs
editas
editing
exits
experimental
fda
gene
genetic
legacy
medicines
news
nods
opioid
pact
partnership
past
pruning
regulatory
research
returning
rights
roundup
sarepta’s
seven
shkreli’s
slow
stumble
suits
tends
terminated
treatment
Language
unset
Current search:
allergan
×
biotech
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
